Association of bleeding with serotonergic antidepressants in patients receiving left ventricular assist device support

Abstract

Continuous-flow left ventricular assist devices (CF-LVADs) have become a valuable treatment option for select patients with end-stage heart failure refractory to optimal medical management. CF-LVADs serve as both a bridge to transplant and as destination therapy due to significant improvements in long-term survival and superior patient quality of life. 1